Sat.Dec 21, 2024 - Fri.Dec 27, 2024

article thumbnail

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacy of America

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

article thumbnail

Pain Management: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read pain management stories from the year 2024.

185
185
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: The DEA’s 2025 quotas for opioids will leave seriously ill patients in pain

STAT

A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.

145
145
article thumbnail

FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes

Pharmacy Times

The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.

FDA 152
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Could Ozempic prevent heart attack and stroke?

The Checkup by Singlecare

In a world where the battle against obesity and diabetes is more pressing than ever, a groundbreaking medication is making waves for its dual capabilities. Ozempic (active ingredient semaglutide), a prescription medication manufactured by Novo Nordisk, is approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar in patients with Type 2 diabetes.

FDA 98
article thumbnail

Low Reimbursement, Coverage Restrictions Hinder Access to Vaccines

Drug Topics

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

Vaccines 187

More Trending

article thumbnail

Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis

Pharmacy Times

The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.

149
149
article thumbnail

Amid BIOSECURE Act speculation, WuXi AppTec sells unit

pharmaphorum

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

96
article thumbnail

Drug Topics: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read Drug Topics stories from the year 2024.

186
186
article thumbnail

FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoea

Pharmaceutical Technology

Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

FDA 105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Collective Responsibility, Confidence in Immunizations Indicate Potential of Vaccine Refusal

Pharmacy Times

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Vaccines 132
article thumbnail

Sanofi takes SK Bio-partnered pneumococcal shot into phase 3

pharmaphorum

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.

article thumbnail

COVID-19: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

184
184
article thumbnail

2025 BCMTMS Exam – How To Prepare?

Med Ed 101

I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? – National Board of Medication Therapy Management Eligibility ASK EMPLOYER IF THEY WILL HELP PURCHASE STUDY MATERIALS AND TEST COSTS!!!! About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare?

102
102
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

KRAKEN Trial Highlights Muvalaplin’s Efficacy, Safety in Reducing Lipoprotein(a)

Pharmacy Times

Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).

132
132
article thumbnail

‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK

The Guardian - Pharmaceutical Industry

Guardian review finds many online pharmacies flouting strict advertising rules that govern prescription-only drugs Weight-loss injections are being aggressively marketed to British consumers through often illegal promotions, in a practice experts have described as a wild west industry of drug selling. The booming market for jabs such as Wegovy and Mounjaro has triggered a price battle among online pharmacies, with even high-street chains cashing in on the soaring demand.

87
article thumbnail

Cardiology: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read cardiology stories from the year 2024.

98
article thumbnail

Novo Nordisk sheds billions in value on obesity data

pharmaphorum

Novo Nordisk data on obesity candidate CagriSema falls short of expectations, wiping around $94 billion off its market valuation.

88
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

ASHP Midyear: Pharmacists Play Key Role in Comprehensive COPD Management, Emphasizing Cost Considerations

Pharmacy Times

Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.

139
139
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Despite significant headwinds coming to bear over the past several years, healthcare executives are expecting a favorable 2025, according to a new survey from Deloitte.

79
article thumbnail

Digestive Health: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read digestive health stories from the year 2024.

98
article thumbnail

FDA approves flurry of drugs ahead of holiday season

pharmaphorum

The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.

FDA 79
article thumbnail

Is the PASTEUR Act the Correct Way to Tackle Antibiotic Resistance?

Pharmacy Times

Federal legislation would seek to foster development of antibiotics.

131
131
article thumbnail

‘It’s absolutely open to abuse’: web awash with weight-loss drug offers

The Guardian - Pharmaceutical Industry

Readers describe aggressive online promotions, Black Friday deals and special offers for prescription-only drugs After Andy King was told he was not eligible to receive weight-loss jabs on the NHS, he turned to the internet to order them privately. But before long, he was inundated with promotions. Every other advert on my social media feed is an offer to have a Black Friday deal on the drugs, he said.

72
article thumbnail

Total Pharmacy: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

98
article thumbnail

FDA clears Ionis drug as first therapy for rare disease FCS

pharmaphorum

Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome

FDA 80
article thumbnail

RECAP: 2024 Updates in the GLP-1 Space

Pharmacy Times

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.

article thumbnail

What pharmacists should know about the new drugs approved in 2024

The Checkup by Singlecare

2024 has been a busy year for new drugs. Over 40 new medications have been approved by the FDA, giving patients more options for treating various health problems. These new drugs cover a wide range of conditions, from urinary tract infections to rare genetic disorders. Notable new drugs approved in 2024 By staying up-to-date on the latest drug approvals, pharmacists can give new advice when working with patients and other healthcare providers.

FDA 52
article thumbnail

Giving Pharmacists Prescriptive Authority for Glucagon Would Benefit Patients with Diabetes

Drug Topics

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.

98
article thumbnail

Daiichi and AZ pull Dato-DXd filing in Europe too

pharmaphorum

AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.

76
article thumbnail

Mild IVIG-Related Adverse Events Are Frequent in Children, With Serious Reactions Possible

Pharmacy Times

Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.

137
137
article thumbnail

Gender-affirming surgery disappeared from the U.S. for decades. Now the field is fighting to keep its gains

STAT

For patients who receive gender-affirming surgery, the experience can feel like a rebirth. “I decided that the old me would die on the table and then the new me would come up from it,” said Wendy Grogan, 48, a trans woman who recently pursued vocal and facial procedures, top surgery, and a vaginoplasty — the creation of a vagina from a penis, scrotum, and other tissue.

112
112
article thumbnail

Drug Price Increases Lead to Future Cost Savings for Medicare Beneficiaries

Drug Topics

Provisions under the Inflation Reduction Act have ensured cost savings for patients prescribed drugs covered under Medicare Part B.

98